Biswal S, Mehta R. Cutaneous adverse reactions of chemotherapy in cancer patients: A clinicoepidemiological study. Indian J Dermatol. 2018;63:41.

PubMed  PubMed Central  Google Scholar 

Salah S, Kerob D, Pages Laurent C, Lacouture M, Sibaud V. Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration’s Adverse Event Reporting System dataset. J Am Acad Dermatol. 2024;91:863–71.

CAS  PubMed  Google Scholar 

Deutsch A, Leboeuf NR, Lacouture ME, McLellan BN. Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy. American Society of Clinical Oncology Educational Book; 2020. p. 485–500.

Google Scholar 

Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: A useful clinical term. J Am Acad Dermatol. 2008;59:524–9.

PubMed  Google Scholar 

Hunjan MK, Nowsheen S, Ramos-Rodriguez AJ, Hashmi SK, Bridges AG, Lehman JS, El-Azhary R. Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. 2019;12:19–25.

CAS  PubMed  Google Scholar 

Cole DW, Menge TD, Lowe L, Chan MP, Bresler SC. Clinical and Histopathologic Spectrum of Toxic Erythema of Chemotherapy: A Series of 56 Cases From a Single Institution. Am J Dermatopathol. 2024;46:337–45.

PubMed  Google Scholar 

Miller KK, Gorcey L, McLellan BN. Chemotherapy-induced hand-foot syndrome and nail changes: A review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol. 2014;71:787–94.

PubMed  Google Scholar 

Smith SM, Milam PB, Fabbro SK, Gru AA, Kaffenberger BH. Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition. JAAD Case Rep. 2016;2:476–81.

PubMed  PubMed Central  Google Scholar 

Lu A, Endicott A, Tan SY, Klufas DM, Merrill E, Arakaki R, LeBoit PE, Fox L, Haemel A. Toxic epidermal necrolysis-like toxic erythema of chemotherapy: 2 illustrative cases. JAAD Case Rep. 2021;15:56–9.

PubMed  PubMed Central  Google Scholar 

Horn TD. Observations and Proposed Mechanism of N,N′,N″-Triethylenethiophosphoramide (Thiotepa)-Induced Hyperpigmentation. Arch Dermatol. 1989;125:524.

CAS  PubMed  Google Scholar 

Zhang B, Bolognia J, Marks P, Podoltsev N. Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemia. Cancer Chemother Pharmacol. 2014;74:303–7.

CAS  PubMed  Google Scholar 

Brockow K. Detection of drug-specific immunoglobulin E (IgE) and acute mediator release for the diagnosis of immediate drug hypersensitivity reactions. J Immunol Methods. 2021;496:113101.

CAS  PubMed  Google Scholar 

Pichler WJ. Delayed Drug Hypersensitivity Reactions. Ann Intern Med. 2003;139:683–93.

CAS  PubMed  Google Scholar 

Nikolaou V, Syrigos K, Saif MW. Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf. 2016;15:1625–33.

CAS  PubMed  Google Scholar 

Pugalia N, Singh R, Madke B, Rusia K, Jaiswal S. Capecitabine-induced palmo-plantar erythrodysesthesia (toxic erythema of chemotherapy). Dermatol Online J. 2023; https://doi.org/10.5070/D329160225.

do Nascimento ADA, Porto DM, de L VAK. Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome – A literature review. An Bras Dermatol. 2023;98:302–9.

PubMed  PubMed Central  Google Scholar 

Whorton AE, Razzak AN, Jha P. Hand-Foot Syndrome Presentation Post-Capecitabine Treatment in a Black Patient. Cureus. 2022; https://doi.org/10.7759/cureus.26891.

Huang J, Ye S, Feng S, Zheng M, Zhong M. Prevalence of hand-foot syndrome following chemotherapy for colorectal cancer: a systematic review and meta-analysis. Int J Color Dis. 2023;38:61.

Google Scholar 

Pandy JGP, Franco PIG, Li RK. Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials. Support Care Cancer. 2022;30:8655–66.

PubMed  Google Scholar 

Lassere Y, Hoff P. Management of hand-foot syndrome in patients treated with capecitabine (Xeloda®). Eur J Oncol Nurs. 2004;8:S31–40.

PubMed  Google Scholar 

Kwakman JJM, Elshot YS, Punt CJA, Koopman M. Management of cytotoxic chemotherapy-induced hand-foot syndrome. Oncol Rev. 2020; https://doi.org/10.4081/oncol.2020.442.

Zhao J, Zhang X, Cui X, Wang D, Zhang B, Ban L. Loss of Fingerprints as a Side Effect of Capecitabine Therapy: Case Report and Literature Review. Oncol Res. 2020;28:103–6.

PubMed  PubMed Central  Google Scholar 

Rzepecki AK, Franco L, McLellan BN. PATEO syndrome: periarticular thenar erythema with onycholysis. Acta Oncol. 2018;57:991–2.

PubMed  Google Scholar 

Kaur J, Gaurav V, Tyagi M. Paclitaxel-Induced Periarticular Thenar Erythema with Onycholysis Syndrome. Skin Appendage Disord. 2024;10:74–7.

PubMed  Google Scholar 

Charron-Ligez F, Désy D, Auclair M-H. Paclitaxel-induced periarticular thenar eminence erythema with onycholysis: A case report. SAGE Open Med Case Rep. 2023; https://doi.org/10.1177/2050313X231213930.

Chanprapaph K, Rutnin S, Vachiramon V. Multikinase Inhibitor-Induced Hand–Foot Skin Reaction: A Review of Clinical Presentation, Pathogenesis, and Management. Am J Clin Dermatol. 2016;17:387–402.

PubMed  Google Scholar 

Shou L, Chen J, Shao T, Zhang Y, Zhao S, Chen S, Shu Q. Clinical characteristics, treatment outcomes, and prognosis in patients with MKIs-associated hand-foot skin reaction: a retrospective study. Support Care Cancer. 2023;31:375.

PubMed  Google Scholar 

Said JT, Singer S, Iannattone L, Sauder M, LeBoeuf NR. Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor–Induced Hand-Foot Skin Reaction. JAMA Dermatol. 2022;158:824.

PubMed  PubMed Central  Google Scholar 

Lee Y-S, Jung YK, Kim JH, et al. Effect of urea cream on sorafenib-associated hand–foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study. Eur J Cancer. 2020;140:19–27.

CAS  PubMed  Google Scholar 

Huang W-K, Hsu H-C, Yang T-S, Lu C-W, Pan Y-R, Wu C-E, Chung W-H, Hung S-I, Yeh C-N. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial. J Am Acad Dermatol. 2024;90:368–9.

CAS  PubMed  Google Scholar 

Lu C-W, Yeh C-N, Hsu H-C, Chen C-B, Yang T-S, Pan Y-R, Chung W-H, Hung S-I. Zinc supplementation is associated with improvement in hand-foot skin reaction in patients on vascular endothelial growth factor receptor-tyrosine kinase inhibitors: A cohort study. J Am Acad Dermatol. 2024;90:814–5.

CAS  PubMed  Google Scholar 

Zhu Y, Zhang X, Lou X, Chen M, Luo P, He Q. Vascular endothelial growth factor (VEGF) antibody significantly increases the risk of hand–foot skin reaction to multikinase inhibitors (MKIs): A systematic literature review and meta-analysis. Clin Exp Pharmacol Physiol. 2018;45:659–67.

CAS  PubMed  PubMed Central  Google Scholar 

Ding F, Liu B, Wang Y. Risk of hand-foot skin reaction associated with vascular endothelial growth factor–tyrosine kinase inhibitors: A meta-analysis of 57 randomized controlled trials involving 24,956 patients. J Am Acad Dermatol. 2020;83:788–96.

CAS  PubMed  Google Scholar 

Nguyen GH, Camilleri MJ, Wetter DA. Characterization and Management of Amicrobial Pustulosis of the Folds, Aseptic Abscess Syndrome, Behçet Disease, Neutrophilic Eccrine Hidradenitis, and Pyostomatitis Vegetans−Pyodermatitis Vegetans. Dermatol Clin. 2024;42:231–45.

CAS  PubMed  Google Scholar 

Nelson CA, Stephen S, Ashchyan HJ, James WD, Micheletti RG, Rosenbach M. Neutrophilic dermatoses. J Am Acad Dermatol. 2018;79:987–1006.

PubMed  Google Scholar 

Agarwal A, Samal P, Mohapatra D, Kar BR. Neutrophilic Eccrine Hidradenitis Presenting in a Case of Acute Undifferentiated Leukemia Before Chemotherapy. Indian J Drugs Dermatol. 2021;7:97–8.

Google Scholar 

Isaq NA, Anand N, Camilleri MJ, Mohandesi NA, Alavi A. Neutrophilic eccrine hidradenitis: a retrospective study. Int J Dermatol. 2023;62:1142–6.

CAS  PubMed  Google Scholar 

Baeza-Hernández G, Rubio-Aguilera RF, Horcajada-Reales C, Khedaoui R, Romero-Maté A. Neutrophilic eccrine hidradenitis as a clue to the diagnosis of Behçet’s disease: Case report with excellent response to adalimumab. Australas J Dermatol. 2024; https://doi.org/10.1111/ajd.14212.

Bachmeyer C, Aractingi S. Neutrophilic eccrine hidradenitis. Clin Dermatol. 2000;18:319–30.

CAS  PubMed  Google Scholar 

Weiss EH, Ko CJ, Leung TH, Micheletti RG, Mostaghimi A, Ramachandran SM, Rosenbach M, Nelson CA. Neutrophilic Dermatoses: a Clinical Update. Curr Dermatol Rep. 2022;11:89–102.

PubMed  PubMed Central  Google Scholar 

Choate EA, Sarantopoulos GP, Worswick SD, Truong AK. Thiotepa hyperpigmentation preceding epidermal necrosis: malignant intertrigo misdiagnosed as Stevens-Johnson syndrome-toxic epidermal necrolysis overlap. Dermatol Online J. 2020; https://doi.org/10.5070/D3262047412.

Slater KN, Nessel T, Kartono F. Toxic Erythema of Chemotherapy, Vasculitic Eruption With Malignant Intertrigo Characteristics, and Superimposed Infection Post-bevacizumab Initiation. Cureus. 2024; https://doi.org/10.7759/cureus.52816.

Liu C, Ko M-J. Malignant intertrigo. Can Med Assoc J. 2018;190:E595–5.

Google Scholar 

Chaudet KM, Russell-Goldman E, Horn TD, Schuler AM, Chan MP, Nazarian RM. Characterization of T-Helper Immune Phenotype in Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Endorses a Delayed-Type Hypersensitivity Reaction. Am J Dermatopathol. 2024;46:71–8.

PubMed  Google Scholar 

Carilli A, Favis G, Sundharkrishnan L, Hajdenberg J. Severe Dermatologic Reactions with Bendamustine: A Case Series. Case Rep Oncol. 2014;7:465–70.

PubMed  PubMed Central